The CEO and senior executives of OrganoClick AB choose to acquire 100 % of the warrants in the incentive program proposed by the Board.
Following the decision of the Extraordinary General Meeting on January 12, 2022, OrganoClick AB was able to offer 979,500 warrants to the CEO and senior executives in the form of an incentive program. The Board believes that a personal ownership commitment is to the benefit of the company and the shareholders, while at the same time giving senior executives the opportunity to participate in the value growth they contribute to creating.
All warrants have been subscribed and thus give the company a capital injection of SEK 1,537,815 as of today's date.
This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 14-01-2022 12:34 CET.
This information was distributed by Cision http://www.cisionwire.se/